文献速递肿瘤 PET/CT骨显像与常规 SPECT

飞行时间PET对前列腺癌同期18F-胆碱PET/MRI定量准确性和病灶检测的影响

Impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous 18F-choline PET/MRI for prostate cancer.
PubMed 文献 · EJNMMI Res · 2018-05-31

本研究比较了TOF与非TOF重建的18F-胆碱PET/MRI在前列腺癌患者中的SUV绝对与相对差异及转移灶检出率。结果显示,除颅骨外所有骨性结构、前列腺原发灶及盆腔淋巴结和骨转移灶的非TOF SUV均显著低于TOF;TOF可提高淋巴结和骨转移灶的检出率,读者间一致性在TOF骨转移检测中为好(kappa 0.636),非TOF为中等(kappa 0.600)。

要点

  • 除颅骨外,所有骨性结构、前列腺原发灶及盆腔淋巴结和骨转移灶的非TOF SUV显著低于TOF。
  • 淋巴结转移:两位读者TOF检出16/19(84%),非TOF读者1检出11(58%)、读者2检出14(73%)。
  • 骨转移:TOF读者1检出14/15(93%)、读者2检出11/15(73%);非TOF读者1为73%(11/15)、读者2为53%(8/15)。

核心结论

  • 18F-胆碱PET/MRI的TOF重建在生理骨性结构及盆腔恶性肿瘤中显示的SUV测量值高于非TOF重建。
  • 结果提示加入TOF信息对前列腺癌患者淋巴结和骨转移灶的检出率有积极影响。

研究设计与样本

  • 比较TOF与非TOF 18F-胆碱PET的SUV绝对和相对差异,并分析前列腺癌患者转移灶检出率。

主要发现

  • 除颅骨外,所有骨性结构、前列腺原发灶、盆腔淋巴结转移和骨转移中,非TOF SUV显著低于TOF。
  • 淋巴结转移:两位有经验读者TOF检出16/19(84%);非TOF读者1检出11(58%)、读者2检出14(73%)。
  • 骨转移:TOF读者1检出14/15(93%)、读者2检出11/15(73%);非TOF读者1检出73%(11/15)、读者2检出53%(8/15)。
  • 读者间一致性:TOF骨转移检测为好(kappa 0.636,95%CI 0.453-0.810),非TOF为中等(kappa 0.600,95%CI 0.438-0.780)。

关键数值与推荐

  • 淋巴结转移检出:TOF两位读者均16/19(84%);非TOF读者1为11(58%)、读者2为14(73%)。
  • 骨转移检出:TOF读者1为14/15(93%)、读者2为11/15(73%);非TOF读者1为73%(11/15)、读者2为53%(8/15)。
  • 读者间一致性kappa:TOF 0.636(95%CI 0.453-0.810),非TOF 0.600(95%CI 0.438-0.780)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Accurate attenuation correction (AC) is an inherent problem of positron emission tomography magnetic resonance imaging (PET/MRI) systems. Simulation studies showed that time-of-flight (TOF) detectors can reduce PET quantification errors in MRI-based AC. However, its impact on lesion detection in a clinical setting with 18F-choline has not yet been evaluated. Therefore, we compared TOF and non-TOF 18F-choline PET for absolute and relative difference in standard uptake values (SUV) and investigated the detection rate of metastases in prostate cancer patients. RESULTS: Non-TOF SUV was significantly lower compared to TOF in all osseous structures, except the skull, in primary lesions of the prostate, and in pelvic nodal and osseous metastasis. Concerning lymph node metastases, both experienced readers detected 16/19 (84%) on TOF PET, whereas on non-TOF PET readers 1 and 2 detected 11 (58%), and 14 (73%), respectively. With TOF PET readers 1 and 2 detected 14/15 (93%) and 11/15 (73%) bone metastases, respectively, whereas detection rate with non-TOF PET was 73% (11/15) for reader 1 and 53% (8/15) for reader 2. The interreader agreement was good for osseous metastasis detection on TOF (kappa 0.636, 95% confidence interval [CI] 0.453-0.810) and moderate on non-TOF (kappa = 0.600, CI 0.438-0.780). CONCLUSION: TOF reconstruction for 18F-choline PET/MRI shows higher SUV measurements compared to non-TOF reconstructions in physiological osseous structures as well as pelvic malignancies. Our results suggest that addition of TOF information has a positive impact on lesion detection rate for lymph node and bone metastasis in prostate cancer patients.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Muehlematter UJ, Nagel HW, Becker A, et al. Impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous 18F-choline PET/MRI for prostate cancer. EJNMMI Res. 2018. PMID: 29855728. doi:10.1186/s13550-018-0390-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。